Skip to content
Shuttingdown

Tharimmune, Inc.

Finance Services · NEW YORK · NY

Distress signal

Moderate confidence (50%)

Updated Oct 8, 2026, 12:05 AM

What is happening

Derived by rule set status-rules-2026.09.7

An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

Latest material event: Tharimmune, Inc. received a delisting notice from its exchange (Jan 9, 2026)

Timeline

Every material event, newest first. History is never overwritten.

  1. Tharimmune, Inc. received a delisting notice from its exchange

    Jan 9, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On January 9, 2026, Tharimmune, Inc. (the Company ) received a notification letter from The Nasdaq Stock Market LLC regarding its noncompliance with Nasdaq Listing Rule 5605 ( Rule 5605 ), which requires, among other things, that a majority of the Board of Directors of the Company (the Board ) be comprised of independent directors. As previously disclosed, Nancy Davis and Sanam Parikh resigned as members of the Board, effective as of November 6, 2025 and Mark Wendland was elected to…”

Company information

Founded
—
Employees (estimate)
—
Industry
Finance Services
Subindustry
—
Listing
SEC lists the ticker CNTN on Nasdaq.
SEC CIK
0001861657
Website
—
LinkedIn
—
Headquarters
NEW YORK, NY
Also known as
Hillstream BioPharma Inc., Tharimmune, Inc.
Legal entities
Tharimmune, Inc.

Sources

Every material source used to build this profile.

  • SEC Company Submissions (TIER 1 · UNVERIFIED)

    Canton Strategic Holdings, Inc. — Finance Services (SIC 6199) — NEW YORK, NY
    View source record
  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On January 9, 2026, Tharimmune, Inc. (the Company ) received a notification letter from The Nasdaq Stock Market LLC regarding its noncompliance with Nasdaq Listing Rule 5605 ( Rule 5605 ), which requires, among other things, that a majority of the Board of Directors of the Company (the Board ) be comprised of independent directors. As previously disclosed, Nancy Davis and Sanam Parikh resigned as members of the Board, effective as of November 6, 2025 and Mark Wendland was elected to…
    View source record

Status history

Every derived status, with the rule that produced it.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:30 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:13 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:32 PM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 04:45 PM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:59 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.